000 | 01480 a2200433 4500 | ||
---|---|---|---|
005 | 20250518045212.0 | ||
264 | 0 | _c20191206 | |
008 | 201912s 0 0 eng d | ||
022 | _a1527-3172 | ||
024 | 7 |
_a10.37757/MR2018.V20.N3.6 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOchoa-Azze, Rolando F | |
245 | 0 | 0 |
_aEffectiveness of a Serogroup B and C Meningococcal Vaccine Developed in Cuba. _h[electronic resource] |
260 |
_bMEDICC review _c07 2018 |
||
300 |
_a22-29 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 |
_aBacterial Capsules _ximmunology |
650 | 0 | 4 |
_aBrazil _xepidemiology |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aColombia _xepidemiology |
650 | 0 | 4 | _aCuba |
650 | 0 | 4 |
_aDisease Outbreaks _xprevention & control |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aMeningococcal Infections _xepidemiology |
650 | 0 | 4 |
_aMeningococcal Vaccines _ximmunology |
650 | 0 | 4 |
_aNeisseria meningitidis, Serogroup B _ximmunology |
650 | 0 | 4 |
_aNeisseria meningitidis, Serogroup C _ximmunology |
650 | 0 | 4 |
_aPolysaccharides, Bacterial _ximmunology |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aGarcía-Imía, Luis | |
700 | 1 | _aVérez-Bencomo, Vicente | |
773 | 0 |
_tMEDICC review _gvol. 20 _gno. 3 _gp. 22-29 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.37757/MR2018.V20.N3.6 _zAvailable from publisher's website |
999 |
_c29838807 _d29838807 |